{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T03:48:11Z","timestamp":1792986491873,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1016\/j.vaccine.2007.10.055","type":"journal-article","created":{"date-parts":[[2007,12,5]],"date-time":"2007-12-05T16:58:29Z","timestamp":1196873909000},"page":"153-157","source":"Crossref","is-referenced-by-count":59,"title":["Immunization with West Nile virus envelope domain III protects mice against lethal infection with homologous and heterologous virus"],"prefix":"10.1016","volume":"26","author":[{"given":"Byron E.","family":"Martina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penelopie","family":"Koraka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"van den Doel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geert","family":"van Amerongen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guus F.","family":"Rimmelzwaan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert D.M.E.","family":"Osterhaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.vaccine.2007.10.055_bib1","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/00019052-200306000-00023","article-title":"Exotic and emerging viral encephalitides","volume":"16","author":"Solomon","year":"2003","journal-title":"Curr Opin Neurol"},{"issue":"2","key":"10.1016\/j.vaccine.2007.10.055_bib2","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1080\/13550280390194037","article-title":"Recent advances in Japanese encephalitis","volume":"9","author":"Solomon","year":"2003","journal-title":"J Neurovirol"},{"issue":"39","key":"10.1016\/j.vaccine.2007.10.055_bib3","first-page":"877","article-title":"Possible West Nile virus transmission to an infant through breast-feeding\u2014Michigan, 2002","volume":"51","year":"2002","journal-title":"MMWR MorbMortalWklyRep"},{"key":"10.1016\/j.vaccine.2007.10.055_bib4","unstructured":"From the Centers for Disease Control and Prevention. Possible West Nile virus transmission to an infant through breast-feeding\u2014Michigan, 2002. JAMA 2002;288(16):1976\u20137."},{"issue":"2","key":"10.1016\/j.vaccine.2007.10.055_bib5","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0003-4975(03)00271-6","article-title":"A case of fatal West Nile virus meningoencephalitis associated with receipt of blood transfusions after open heart surgery","volume":"76","author":"Armstrong","year":"2003","journal-title":"Ann Thorac Surg"},{"issue":"8","key":"10.1016\/j.vaccine.2007.10.055_bib6","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1046\/j.1537-2995.2003.00481.x","article-title":"West Nile virus infection transmitted by blood transfusion","volume":"43","author":"Harrington","year":"2003","journal-title":"Transfusion"},{"issue":"13","key":"10.1016\/j.vaccine.2007.10.055_bib7","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1056\/NEJMoa030969","article-title":"Transmission of West Nile virus through blood transfusion in the United States in 2002","volume":"349","author":"Pealer","year":"2003","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.vaccine.2007.10.055_bib8","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1111\/j.1600-6143.2004.00410.x","article-title":"West Nile virus encephalitis in a kidney transplant recipient","volume":"4","author":"Shepherd","year":"2004","journal-title":"Am J Transplant"},{"issue":"2","key":"10.1016\/j.vaccine.2007.10.055_bib9","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1086\/505121","article-title":"Clinical features in children hospitalized during the 2005 epidemic of Japanese encephalitis in Uttar Pradesh, India","volume":"43","author":"Kumar","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2007.10.055_bib10","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s004150050090","article-title":"Movement disorders in Japanese encephalitis","volume":"244","author":"Misra","year":"1997","journal-title":"J Neurol"},{"issue":"12","key":"10.1016\/j.vaccine.2007.10.055_bib11","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1212\/WNL.57.12.2313","article-title":"Persistent movement disorders following Japanese encephalitis","volume":"57","author":"Murgod","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.vaccine.2007.10.055_bib12","first-page":"CD004263","article-title":"Vaccines for preventing Japanese encephalitis","volume":"3","author":"Schioler","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.vaccine.2007.10.055_bib13","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1586\/14787210.4.2.313","article-title":"Japanese encephalitis: development of new candidate vaccines","volume":"4","author":"Bharati","year":"2006","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"10","key":"10.1016\/j.vaccine.2007.10.055_bib14","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1056\/NEJM198809083191004","article-title":"Protection against Japanese encephalitis by inactivated vaccines","volume":"319","author":"Hoke","year":"1988","journal-title":"N Engl J Med"},{"issue":"26","key":"10.1016\/j.vaccine.2007.10.055_bib15","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1016\/S0264-410X(00)00111-0","article-title":"Adverse events after Japanese encephalitis vaccination: review of post-marketing surveillance data from Japan and the United States. The VAERS Working Group","volume":"18","author":"Takahashi","year":"2000","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2007.10.055_bib16","doi-asserted-by":"crossref","first-page":"5579","DOI":"10.1128\/JVI.65.10.5579-5583.1991","article-title":"The flavivirus envelope protein E: isolation of a soluble form from tick-borne encephalitis virus and its crystallization","volume":"65","author":"Heinz","year":"1991","journal-title":"J Virol"},{"issue":"23","key":"10.1016\/j.vaccine.2007.10.055_bib17","doi-asserted-by":"crossref","first-page":"11467","DOI":"10.1128\/JVI.01125-06","article-title":"Crystal structure of the West Nile virus envelope glycoprotein","volume":"80","author":"Nybakken","year":"2006","journal-title":"J Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2007.10.055_bib18","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1128\/JVI.77.4.2600-2606.2003","article-title":"A functional epitope determinant on domain III of the Japanese encephalitis virus envelope protein interacted with neutralizing-antibody combining sites","volume":"77","author":"Lin","year":"2003","journal-title":"J Virol"},{"issue":"Pt 8","key":"10.1016\/j.vaccine.2007.10.055_bib19","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1099\/0022-1317-70-8-2037","article-title":"Molecular characterization of a neutralizing domain of the Japanese encephalitis virus structural glycoprotein","volume":"70","author":"Mason","year":"1989","journal-title":"J Gen Virol"},{"issue":"7059","key":"10.1016\/j.vaccine.2007.10.055_bib20","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/nature03956","article-title":"Structural basis of West Nile virus neutralization by a therapeutic antibody","volume":"437","author":"Nybakken","year":"2005","journal-title":"Nature"},{"issue":"46","key":"10.1016\/j.vaccine.2007.10.055_bib21","doi-asserted-by":"crossref","first-page":"46007","DOI":"10.1074\/jbc.M307776200","article-title":"Structural basis of a flavivirus recognized by its neutralizing antibody: solution structure of the domain III of the Japanese encephalitis virus envelope protein","volume":"278","author":"Wu","year":"2003","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.vaccine.2007.10.055_bib22","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/BF01309857","article-title":"Tick-borne encephalitis virus envelope protein E-specific monoclonal antibodies for the study of low pH-induced conformational changes and immature virions","volume":"140","author":"Holzmann","year":"1995","journal-title":"Arch Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2007.10.055_bib23","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0168-1702(01)00246-5","article-title":"Neutralizing peptide ligands selected from phage-displayed libraries mimic the conformational epitope on domain III of the Japanese encephalitis virus envelope protein","volume":"76","author":"Wu","year":"2001","journal-title":"Virus Res"},{"issue":"5","key":"10.1016\/j.vaccine.2007.10.055_bib24","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.4049\/jimmunol.178.5.2699","article-title":"Immunization of flavivirus West Nile recombinant envelope domain III protein induced specific immune response and protection against West Nile virus infection","volume":"178","author":"Chu","year":"2007","journal-title":"J Immunol"},{"issue":"26","key":"10.1016\/j.vaccine.2007.10.055_bib25","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.1016\/j.vaccine.2004.12.028","article-title":"Induction of protective antibodies against dengue virus by tetravalent DNA immunization of mice with domain III of the envelope protein","volume":"23","author":"Mota","year":"2005","journal-title":"Vaccine"},{"issue":"19\/20","key":"10.1016\/j.vaccine.2007.10.055_bib26","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1016\/S0264-410X(03)00042-2","article-title":"The domain III fragment of Japanese encephalitis virus envelope protein: mouse immunogenicity and liposome adjuvanticity","volume":"21","author":"Wu","year":"2003","journal-title":"Vaccine"},{"issue":"Pt 2","key":"10.1016\/j.vaccine.2007.10.055_bib27","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1099\/vir.0.80411-0","article-title":"Inhibition of West Nile virus entry by using a recombinant domain III from the envelope glycoprotein","volume":"86","author":"Chu","year":"2005","journal-title":"J Gen Virol"},{"issue":"35","key":"10.1016\/j.vaccine.2007.10.055_bib28","doi-asserted-by":"crossref","first-page":"4385","DOI":"10.1016\/j.vaccine.2005.04.011","article-title":"Augmentation of immune responses to SARS coronavirus by a combination of DNA and whole killed virus vaccines","volume":"23","author":"Zakhartchouk","year":"2005","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2007.10.055_bib29","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1084\/jem.186.10.1623","article-title":"CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity","volume":"186","author":"Chu","year":"1997","journal-title":"J Exp Med"},{"issue":"24","key":"10.1016\/j.vaccine.2007.10.055_bib30","doi-asserted-by":"crossref","first-page":"13097","DOI":"10.1128\/JVI.76.24.13097-13100.2002","article-title":"Identification of neutralizing epitopes within structural domain III of the West Nile virus envelope protein","volume":"76","author":"Beasley","year":"2002","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2007.10.055_bib31","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/0042-6822(89)90044-5","article-title":"Epitope model of tick-borne encephalitis virus envelope glycoprotein E: analysis of structural properties, role of carbohydrate side chain, and conformational changes occurring at acidic pH","volume":"169","author":"Guirakhoo","year":"1989","journal-title":"Virology"},{"issue":"12","key":"10.1016\/j.vaccine.2007.10.055_bib32","doi-asserted-by":"crossref","first-page":"6986","DOI":"10.1073\/pnas.0832193100","article-title":"A ligand-binding pocket in the dengue virus envelope glycoprotein","volume":"100","author":"Modis","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2007.10.055_bib33","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0065-3527(03)59005-4","article-title":"Antigenic structure of flavivirus proteins","volume":"59","author":"Roehrig","year":"2003","journal-title":"Adv Virus Res"},{"issue":"6529","key":"10.1016\/j.vaccine.2007.10.055_bib34","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/375291a0","article-title":"The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution","volume":"375","author":"Rey","year":"1995","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.vaccine.2007.10.055_bib35","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00430-007-0043-4","article-title":"Immunogenicity and protective efficacy of the E. coli-expressed domain III of Japanese encephalitis virus envelope protein in mice","volume":"196","author":"Alka","year":"2007","journal-title":"Med Microbiol Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2007.10.055_bib36","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.virusres.2006.04.003","article-title":"Amino acid changes in the recombinant Dengue 3 Envelope domain III determine its antigenicity and immunogenicity in mice","volume":"121","author":"Zulueta","year":"2006","journal-title":"Virus Res"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07012479?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07012479?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,29]],"date-time":"2020-04-29T04:44:05Z","timestamp":1588135445000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X07012479"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S0264410X07012479"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2007.10.055","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]}}}